APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal-derived Immune Globulin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal-derived Immune Globulin Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchAnimal-derived Immune Globulin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal-derived Immune Globulin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Animal-derived Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal-derived Immune Globulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal-derived Immune Globulin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Animal-derived Immune Globulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal-derived Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal-derived Immune Globulin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal-derived Immune Globulin market include Sanofi, Merck, Pfizer, Wyeth Pharmaceuticals, Rare Disease Therapeutics, Protherics and Genzyme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal-derived Immune Globulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal-derived Immune Globulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal-derived Immune Globulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal-derived Immune Globulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal-derived Immune Globulin Segment by Company

Sanofi

Merck

Pfizer

Wyeth Pharmaceuticals

Rare Disease Therapeutics

Protherics

Genzyme

Animal-derived Immune Globulin Segment by Type

Liquid

Powder

Animal-derived Immune Globulin Segment by Application

Hospital

Clinic

Animal-derived Immune Globulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal-derived Immune Globulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal-derived Immune Globulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal-derived Immune Globulin significant trends, drivers, influence factors in global and regions.

6. To analyze Animal-derived Immune Globulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal-derived Immune Globulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal-derived Immune Globulin industry.

Chapter 3: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal-derived Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal-derived Immune Globulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal-derived Immune Globulin Industry Trends Table 2. Animal-derived Immune Globulin Industry Drivers Table 3. Animal-derived Immune Globulin Industry Opportunities and Challenges Table 4. Animal-derived Immune Globulin Industry Restraints Table 5. Global Animal-derived Immune Globulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal-derived Immune Globulin Revenue Share by Company (2021-2026) Table 7. Global Animal-derived Immune Globulin Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Animal-derived Immune Globulin Sales Volume Share by Company (2021-2026) Table 9. Global Animal-derived Immune Globulin Average Price (US$/ton) of Company (2021-2026) Table 10. Global Animal-derived Immune Globulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal-derived Immune Globulin Key Company Manufacturing Base & Headquarters Table 12. Global Animal-derived Immune Globulin Company, Product Type & Application Table 13. Global Animal-derived Immune Globulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal-derived Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liquid Table 18. Significant Companies of Powder Table 19. Global Animal-derived Immune Globulin Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global Animal-derived Immune Globulin Sales Volume by Type (2021-2026) & (k tons) Table 21. Global Animal-derived Immune Globulin Sales Volume by Type (2027-2032) & (k tons) Table 22. Global Animal-derived Immune Globulin Sales Volume Share by Type (2021-2026) Table 23. Global Animal-derived Immune Globulin Sales Volume Share by Type (2027-2032) Table 24. Global Animal-derived Immune Globulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Animal-derived Immune Globulin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Animal-derived Immune Globulin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Animal-derived Immune Globulin Sales Value Share by Type (2021-2026) Table 28. Global Animal-derived Immune Globulin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Animal-derived Immune Globulin Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 32. Global Animal-derived Immune Globulin Sales Volume by Application (2021-2026) & (k tons) Table 33. Global Animal-derived Immune Globulin Sales Volume by Application (2027-2032) & (k tons) Table 34. Global Animal-derived Immune Globulin Sales Volume Share by Application (2021-2026) Table 35. Global Animal-derived Immune Globulin Sales Volume Share by Application (2027-2032) Table 36. Global Animal-derived Immune Globulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Animal-derived Immune Globulin Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Animal-derived Immune Globulin Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Animal-derived Immune Globulin Sales Value Share by Application (2021-2026) Table 40. Global Animal-derived Immune Globulin Sales Value Share by Application (2027-2032) Table 41. Global Animal-derived Immune Globulin Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 42. Global Animal-derived Immune Globulin Sales by Region (2021-2026) & (k tons) Table 43. Global Animal-derived Immune Globulin Sales Market Share by Region (2021-2026) Table 44. Global Animal-derived Immune Globulin Sales by Region (2027-2032) & (k tons) Table 45. Global Animal-derived Immune Globulin Sales Market Share by Region (2027-2032) Table 46. Global Animal-derived Immune Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Animal-derived Immune Globulin Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Animal-derived Immune Globulin Sales Value Share by Region (2021-2026) Table 49. Global Animal-derived Immune Globulin Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Animal-derived Immune Globulin Sales Value Share by Region (2027-2032) Table 51. Global Animal-derived Immune Globulin Market Average Price (US$/ton) by Region (2021-2026) Table 52. Global Animal-derived Immune Globulin Market Average Price (US$/ton) by Region (2027-2032) Table 53. Global Animal-derived Immune Globulin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Global Animal-derived Immune Globulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Animal-derived Immune Globulin Sales by Country (2021-2026) & (k tons) Table 56. Global Animal-derived Immune Globulin Sales Market Share by Country (2021-2026) Table 57. Global Animal-derived Immune Globulin Sales by Country (2027-2032) & (k tons) Table 58. Global Animal-derived Immune Globulin Sales Market Share by Country (2027-2032) Table 59. Global Animal-derived Immune Globulin Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Animal-derived Immune Globulin Sales Value Market Share by Country (2021-2026) Table 61. Global Animal-derived Immune Globulin Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Animal-derived Immune Globulin Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Sanofi Animal-derived Immune Globulin Product Portfolio Table 67. Sanofi Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Merck Animal-derived Immune Globulin Product Portfolio Table 72. Merck Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Pfizer Animal-derived Immune Globulin Product Portfolio Table 77. Pfizer Recent Development Table 78. Wyeth Pharmaceuticals Company Information Table 79. Wyeth Pharmaceuticals Business Overview Table 80. Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio Table 82. Wyeth Pharmaceuticals Recent Development Table 83. Rare Disease Therapeutics Company Information Table 84. Rare Disease Therapeutics Business Overview Table 85. Rare Disease Therapeutics Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio Table 87. Rare Disease Therapeutics Recent Development Table 88. Protherics Company Information Table 89. Protherics Business Overview Table 90. Protherics Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Protherics Animal-derived Immune Globulin Product Portfolio Table 92. Protherics Recent Development Table 93. Genzyme Company Information Table 94. Genzyme Business Overview Table 95. Genzyme Animal-derived Immune Globulin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Genzyme Animal-derived Immune Globulin Product Portfolio Table 97. Genzyme Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Animal-derived Immune Globulin Distributors List Table 101. Animal-derived Immune Globulin Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Animal-derived Immune Globulin Product Image Figure 2. Global Animal-derived Immune Globulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal-derived Immune Globulin Sales (2021-2032) & (k tons) Figure 5. Global Animal-derived Immune Globulin Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Animal-derived Immune Globulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liquid Image Figure 10. Powder Image Figure 11. Global Animal-derived Immune Globulin Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global Animal-derived Immune Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Animal-derived Immune Globulin Sales Volume Share by Type (2021-2032) Figure 14. Global Animal-derived Immune Globulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Animal-derived Immune Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Animal-derived Immune Globulin Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Animal-derived Immune Globulin Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 20. Global Animal-derived Immune Globulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Animal-derived Immune Globulin Sales Volume Share by Application (2021-2032) Figure 22. Global Animal-derived Immune Globulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Animal-derived Immune Globulin Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Animal-derived Immune Globulin Sales Value Share by Application (2021-2032) Figure 25. Global Animal-derived Immune Globulin Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 26. Global Animal-derived Immune Globulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Animal-derived Immune Globulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Animal-derived Immune Globulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 30. North America Animal-derived Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Animal-derived Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Animal-derived Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 36. South America Animal-derived Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Animal-derived Immune Globulin Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Animal-derived Immune Globulin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Animal-derived Immune Globulin Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Animal-derived Immune Globulin Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Hospital
  • Clinic
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • Wyeth Pharmaceuticals
  • Rare Disease Therapeutics
  • Protherics
  • Genzyme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal-derived Immune Globulin Sales Value (2021-2032)
  4. 1.2.2 Global Animal-derived Immune Globulin Sales Volume (2021-2032)
  5. 1.2.3 Global Animal-derived Immune Globulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal-derived Immune Globulin Market Dynamics
  1. 2.1 Animal-derived Immune Globulin Industry Trends
  2. 2.2 Animal-derived Immune Globulin Industry Drivers
  3. 2.3 Animal-derived Immune Globulin Industry Opportunities and Challenges
  4. 2.4 Animal-derived Immune Globulin Industry Restraints
3 Animal-derived Immune Globulin Market by Company
  1. 3.1 Global Animal-derived Immune Globulin Company Revenue Ranking in 2025
  2. 3.2 Global Animal-derived Immune Globulin Revenue by Company (2021-2026)
  3. 3.3 Global Animal-derived Immune Globulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal-derived Immune Globulin Average Price by Company (2021-2026)
  5. 3.5 Global Animal-derived Immune Globulin Company Ranking (2024-2026)
  6. 3.6 Global Animal-derived Immune Globulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal-derived Immune Globulin Company Product Type and Application
  8. 3.8 Global Animal-derived Immune Globulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal-derived Immune Globulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal-derived Immune Globulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal-derived Immune Globulin Market by Type
  1. 4.1 Animal-derived Immune Globulin Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Powder
  4. 4.2 Global Animal-derived Immune Globulin Sales Volume by Type
  5. 4.2.1 Global Animal-derived Immune Globulin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Animal-derived Immune Globulin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Animal-derived Immune Globulin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Animal-derived Immune Globulin Sales Value by Type
  9. 4.3.1 Global Animal-derived Immune Globulin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Animal-derived Immune Globulin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Animal-derived Immune Globulin Sales Value Share by Type (2021-2032)
5 Animal-derived Immune Globulin Market by Application
  1. 5.1 Animal-derived Immune Globulin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Animal-derived Immune Globulin Sales Volume by Application
  5. 5.2.1 Global Animal-derived Immune Globulin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Animal-derived Immune Globulin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Animal-derived Immune Globulin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Animal-derived Immune Globulin Sales Value by Application
  9. 5.3.1 Global Animal-derived Immune Globulin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Animal-derived Immune Globulin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Animal-derived Immune Globulin Sales Value Share by Application (2021-2032)
6 Animal-derived Immune Globulin Regional Sales and Value Analysis
  1. 6.1 Global Animal-derived Immune Globulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal-derived Immune Globulin Sales by Region (2021-2032)
  3. 6.2.1 Global Animal-derived Immune Globulin Sales by Region: 2021-2026
  4. 6.2.2 Global Animal-derived Immune Globulin Sales by Region (2027-2032)
  5. 6.3 Global Animal-derived Immune Globulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal-derived Immune Globulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal-derived Immune Globulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal-derived Immune Globulin Sales Value by Region (2027-2032)
  9. 6.5 Global Animal-derived Immune Globulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal-derived Immune Globulin Sales Value (2021-2032)
  12. 6.6.2 North America Animal-derived Immune Globulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal-derived Immune Globulin Sales Value (2021-2032)
  15. 6.7.2 Europe Animal-derived Immune Globulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal-derived Immune Globulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal-derived Immune Globulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal-derived Immune Globulin Sales Value (2021-2032)
  21. 6.9.2 South America Animal-derived Immune Globulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal-derived Immune Globulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal-derived Immune Globulin Sales Value Share by Country, 2025 VS 2032
7 Animal-derived Immune Globulin Country-level Sales and Value Analysis
  1. 7.1 Global Animal-derived Immune Globulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal-derived Immune Globulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal-derived Immune Globulin Sales by Country (2021-2032)
  4. 7.3.1 Global Animal-derived Immune Globulin Sales by Country (2021-2026)
  5. 7.3.2 Global Animal-derived Immune Globulin Sales by Country (2027-2032)
  6. 7.4 Global Animal-derived Immune Globulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal-derived Immune Globulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal-derived Immune Globulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal-derived Immune Globulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal-derived Immune Globulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal-derived Immune Globulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Animal-derived Immune Globulin Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal-derived Immune Globulin Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Animal-derived Immune Globulin Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Wyeth Pharmaceuticals
  20. 8.4.1 Wyeth Pharmaceuticals Company Information
  21. 8.4.2 Wyeth Pharmaceuticals Business Overview
  22. 8.4.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio
  24. 8.4.5 Wyeth Pharmaceuticals Recent Developments
  25. 8.5 Rare Disease Therapeutics
  26. 8.5.1 Rare Disease Therapeutics Company Information
  27. 8.5.2 Rare Disease Therapeutics Business Overview
  28. 8.5.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio
  30. 8.5.5 Rare Disease Therapeutics Recent Developments
  31. 8.6 Protherics
  32. 8.6.1 Protherics Company Information
  33. 8.6.2 Protherics Business Overview
  34. 8.6.3 Protherics Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Protherics Animal-derived Immune Globulin Product Portfolio
  36. 8.6.5 Protherics Recent Developments
  37. 8.7 Genzyme
  38. 8.7.1 Genzyme Company Information
  39. 8.7.2 Genzyme Business Overview
  40. 8.7.3 Genzyme Animal-derived Immune Globulin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Genzyme Animal-derived Immune Globulin Product Portfolio
  42. 8.7.5 Genzyme Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal-derived Immune Globulin Value Chain Analysis
  2. 9.1.1 Animal-derived Immune Globulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal-derived Immune Globulin Sales Mode & Process
  6. 9.2 Animal-derived Immune Globulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal-derived Immune Globulin Distributors
  9. 9.2.3 Animal-derived Immune Globulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst